Mediclinic International plc confirms that Mr. Seamus Keating, who serves as an independent non-executive director, will step down from the Board of Mediclinic on 31 March 2020. Mr. Keating's intention to retire from the Board was announced subsequent to his appointment as Chief Executive Officer of First Derivatives plc with effect from 15 January 2020. Mr. Keating will also resign from all Board subcommittees at that time which include the Audit and Risk Committee, Remuneration Committee and Clinical Performance and Sustainability Committee.